Literature DB >> 2054362

Prevalence and correlates of perimenstrual symptoms: a study of Israeli teenage girls.

D Shye1, B Jaffe.   

Abstract

The prevalence of common premenstrual symptoms and menstrual period pain were studied in a cohort of 545 Israeli adolescent girls aged 16 to 21 years, and their correlation with biological, behavioral, and sociocultural traits were analyzed. A high proportion of the girls (80%) commonly experienced at least one premenstrual symptom. About 70% experienced menstrual pain in the past and 25% reported pain which severely interfered with daily activities during the last three cycles. Premenstrual symptoms and menstrual pain were positively associated. Oral contraceptive use appeared to reduce the prevalence of menstrual pain, and among smokers who had menstrual pain, heavier smokers experienced more pain. Girls of Asian or African ethnic origin reported consistently higher perimenstrual distress than those of Israeli or Western origin, suggesting that social expectations may affect the perception and reporting of these symptoms.

Entities:  

Mesh:

Year:  1991        PMID: 2054362     DOI: 10.1016/0197-0070(91)90014-d

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  3 in total

1.  The Jerusalem Perinatal Study cohort, 1964-2005: methods and a review of the main results.

Authors:  Susan Harlap; A Michael Davies; Lisa Deutsch; Ronit Calderon-Margalit; Orly Manor; Ora Paltiel; Efrat Tiram; Rivka Yanetz; Mary C Perrin; Mary B Terry; Dolores Malaspina; Yechiel Friedlander
Journal:  Paediatr Perinat Epidemiol       Date:  2007-05       Impact factor: 3.980

Review 2.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

Review 3.  Methods for studying naturally occurring human pain and their analogues.

Authors:  David J Moore; Edmund Keogh; Geert Crombez; Christopher Eccleston
Journal:  Pain       Date:  2012-08-15       Impact factor: 6.961

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.